Bioactive peptides provide a number of health benefits such as immune modulation, antihypertensive effects, antidiabetic properties, antioxidant activity, and assist with calcium absorption making them widely used in functional foods, dietary supplements, medical foods, and clinical nutrition.
Bioactive peptides are short chains of amino acids that provide numerous health promoting benefits. They can be derived by enzymatic hydrolysis of food proteins or by microbial fermentation. Common sources of biopeptides include whey, casein, soy, egg, collagen, and rice among others. Bioactive peptides play important roles in reducing blood pressure, boosting immunity, improving gut health, and aiding weight management. The increasing awareness regarding health benefits of functional ingredients is driving the demand for nutraceuticals and functional foods containing bioactive peptides.
The Global Bioactive Peptide Market Demand is estimated to be valued at US$ 11.29 Bn in 2024 and is expected to exhibit a CAGR of 8.0% over the forecast period of 2024 to 2030.
Key Takeaways
Key players operating in the bioactive peptide market are Archer Daniels Midland Company, Seagarden AS, Phermpep Co. Ltd., Arlak Biotech Pvt. Ltd., Naturade, Royal DSM, MYOS RENS Technology Inc., Natural Factors Inc., Valio Oy, GenScript, HELIX BIOMEDIX, Oryn Therapeutics, Selecta Biosciences, NIBEC, vivitide, PEPTIDE INSTITUTE, INC, BCN Peptides, Setlance srl., APEPTICO Forschung und Entwicklung GmbH, and BIONANOPLUS. These companies are launching new products containing bioactive peptides and engaging in mergers and acquisitions to expand their market share.
The demand for bioactive peptides is growing owing to increasing health conscious consumer base looking for wellness products containing functional ingredients that can provide tangible health benefits. According to a survey, over 70% of global consumers surveyed would choose a nutraceutical product containing bioactive peptides over conventional supplements.
Technological advancements in isolation and purification techniques allow production of new generation bioactive peptides in commercial quantities at competitive prices. Extraction using membrane filtration and chromatography methods help attain high purity bioactive fractions. Identification of novel biopeptide sequences from various sources through proteomics also aids new product development.
Market Trends
Customization is an emerging trend in the bioactive peptide market with companies developing peptides targeted for specific health conditions and consumer segments. Products containing novel biopeptide blends aimed at multi-targeted benefits are gaining popularity. Another major trend is the increasing applications of marine derived bioactive peptides in cosmeceuticals due to their antioxidant and anti-ageing properties.
Market Opportunities
The growing vegan consumer base presents an opportunity for companies to develop plant-based sources of bioactive peptides. Algae, yeasts and microbes offer sustainable alternatives and may yield novel peptides. Another key opportunity lies in developing clinical grade bioactive peptides for therapeutic areas of cardiovascular, metabolic disorders and gut health which have huge market potential.
Impact of COVID-19 on Bioactive Peptide Market
The outbreak of COVID-19 has impacted the bioactive peptide market growth in multiple ways. Globally, lockdowns and social distancing measures disrupted manufacturing and supply chains. This led to shortage of raw materials, impacting research and development activities initially. However, as the pandemic exposed the limitations of conventional medicines and increasing consumer awareness about health and immunity, the demand for immunity boosting and wellness products increased significantly. This provided opportunities for bioactive peptides manufacturers to step up production and introduce new products focused on enhancing immunity. Additionally, increased time spent at homes resulted in more focus on diet and nutrition, benefitting the demand for nutraceuticals containing bioactive peptides.
While the lockdowns impacted businesses globally in 2020, from 2021 onwards, as restrictions eased in many regions, the bioactive peptide market has seen strong recovery and growth. Many manufacturers focused on expanding production capacities and R&D activities to develop clinically proven peptides for treating chronic diseases and boosting immunity. The awareness about health benefits of bioactive peptides rose among consumers due to the pandemic, establishing them as essential ingredients for wellness products. The demand from diet supplement and functional food industries exhibited impressive growth post COVID. Overall, the impact of the pandemic increased focus on preventive healthcare and is poised to accelerate the market growth over the coming years.
Major Geographic Regions for Bioactive Peptide Market in terms of Value
North America accounts for the largest share of the global bioactive peptide market in terms of value, followed by Europe and Asia Pacific. The United States dominates the North America market due to high consumer spending on dietary supplements and nutraceuticals along with presence of major manufacturers in the country. Europe is another highly lucrative region stimulated by rising health and wellness trends as well as increasing demand for bioactive peptides in clinical nutrition.
Asia Pacific region exhibits tremendous growth opportunities for bioactive peptides market, driven by rapidly growing economies, large consumer bases, healthcare investments and changing lifestyles and dietary patterns. In particular, China and India represent two of the fastest growing regional markets. Presence of young and health-conscious population along with expanding middle-class customer segment have boosted the demand for functional ingredients in Asia Pacific. Japan is another prominent country contributing to the Asia Pacific market growth.
Fastest Growing Region for Bioactive Peptide Market
Asia Pacific region is poised to be the fastest growing regional market for bioactive peptides during the forecast period from 2024 to 2030. This is attributed to surging demand from diet supplements, clinical nutrition products and functional food industries across developing economies of China, India and South East Asian countries. Rising healthcare expenditures, growing per capita incomes, increasing life expectancy and expanding middle-class population segments have stimulated the consumption of wellness and preventive healthcare products fortified with bioactive peptides. Additionally, establishment of large-scale production facilities by global ingredient manufacturers is attracting more local producers to this thriving market in Asia Pacific. Therefore, with rapid urbanization, widening consumer awareness and improving standards of living, Asia Pacific offers massive growth prospects for bioactive peptides.
Get more insights on: Bioactive Peptide Market
